Transport
Covenant Medical Center INC
Covenant Medical Center INC was paid $63.08M by Medicaid between Jan 2018 and Dec 2024, across 254 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 58% of everything it billed.
33Billing provider infoCOVENANT MEDICAL CENTER INC
WATERLOO, IA 50702
WATERLOO, IA 50702
33aNPI1700827896assigned 06/09/2006
33bProvider typeAmbulance
28Total paid$63.08M
24GClaims1,081,288
24DCodes billed254
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulance providers in Iowa
Rank by total paid#1 of 45
Median peer was paid$85K
This provider vs. median740×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HUBER, TIMOTHY controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 139,060 | $8.95M | |
| 2019 | 158,578 | $9.98M | |
| 2020 | 134,543 | $7.82M | |
| 2021 | 178,208 | $9.87M | |
| 2022 | 191,546 | $10.06M | |
| 2023 | 174,922 | $9.71M | |
| 2024incomplete | 104,431 | $6.69M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 58% | 385,656 | 347,770 | $36.55M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.4% | 23,697 | 21,569 | $5.27M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.3% | 19,757 | 18,503 | $2.74M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.4% | 5,071 | 4,537 | $2.13M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.9% | 29,780 | 28,929 | $1.20M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.9% | 9,987 | 9,011 | $1.20M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.9% | 19,239 | 6,551 | $1.20M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 12,428 | 11,524 | $976K |
| 41874 | 1.5% | 456 | 362 | $937K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.3% | 10,343 | 10,148 | $824K |
| 20610 | 1.2% | 4,533 | 3,650 | $764K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.1% | 2,002 | 1,681 | $693K |
242 more codes
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.0% | 10,110 | $660K |
| D7311 | <1% | 653 | $583K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,022 | $560K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,959 | $559K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 6,783 | $531K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,739 | $491K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 12,020 | $481K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 6,796 | $323K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 5,072 | $306K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,039 | $278K |
| G0378 | Hospital observation service, per hour | <1% | 4,194 | $273K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 4,910 | $218K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,885 | $202K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,713 | $201K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | <1% | 146 | $175K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,968 | $171K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,051 | $170K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 600 | $150K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,987 | $130K |
| 95911 | <1% | 328 | $111K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 112 | $101K |
| 95250 | <1% | 1,243 | $83K | |
| 95117 | <1% | 2,741 | $80K | |
| 90686 | <1% | 6,925 | $77K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,269 | $71K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 179 | $68K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,163 | $68K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,739 | $63K |
| 80061 | Lipid panel | <1% | 5,330 | $62K |
| D7230 | <1% | 245 | $62K | |
| 92587 | <1% | 273 | $60K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 65,715 | $48K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,692 | $39K |
| 95909 | <1% | 207 | $37K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 105 | $37K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 478 | $37K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | <1% | 429 | $37K |
| 11056 | <1% | 690 | $35K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 509 | $34K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 173 | $34K |
| D1351 | Sealant - per tooth | <1% | 75 | $34K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 100 | $33K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 850 | $33K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 319 | $31K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 114 | $31K |
| 80053 | Comprehensive metabolic panel | <1% | 47,769 | $30K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,690 | $29K |
| 62323 | <1% | 88 | $29K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,570 | $28K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 38 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,197 | $26K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 168 | $26K |
| 92557 | <1% | 523 | $25K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 517 | $25K |
| 43249 | <1% | 27 | $24K | |
| 11721 | <1% | 3,337 | $24K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 5,294 | $23K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 270 | $23K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 58 | $19K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 173 | $18K |
| 92588 | <1% | 116 | $17K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 84 | $16K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 395 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 43,877 | $15K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 44 | $15K |
| G0379 | Direct admission of patient for hospital observation care | <1% | 13 | $15K |
| 90670 | <1% | 2,380 | $14K | |
| 87081 | <1% | 19,009 | $12K | |
| 90651 | <1% | 195 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,412 | $10K |
| 90837 | Psychotherapy session, about an hour | <1% | 366 | $9K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 39 | $9K |
| D7310 | <1% | 16 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 14,619 | $8K |
| 86900 | <1% | 391 | $8K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 61 | $8K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,698 | $8K |
| 83655 | <1% | 2,865 | $8K | |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | <1% | 52 | $7K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 71 | $7K |
| 86780 | <1% | 529 | $7K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 66 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 35,582 | $6K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 106 | $5K |
| 73562 | <1% | 746 | $5K | |
| A0425 | Ground mileage, per statute mile | <1% | 2,738 | $5K |
| 11057 | <1% | 79 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 121 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,270 | $5K |
| 73630 | <1% | 331 | $5K | |
| 85027 | <1% | 5,991 | $5K | |
| 82728 | <1% | 1,538 | $4K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 258 | $4K |
| 70320 | <1% | 33 | $4K | |
| 90723 | <1% | 1,191 | $3K | |
| 0071A | <1% | 71 | $3K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 947 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,696 | $3K |
| 83550 | <1% | 1,000 | $2K | |
| 97161 | <1% | 55 | $2K | |
| 0072A | <1% | 62 | $2K | |
| 92567 | <1% | 2,502 | $2K | |
| 84481 | <1% | 372 | $2K | |
| 59025 | Fetal non-stress test | <1% | 23 | $2K |
| 73564 | <1% | 263 | $2K | |
| 77336 | <1% | 30 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,988 | $2K |
| 83540 | <1% | 1,004 | $2K | |
| 64615 | <1% | 17 | $2K | |
| 51798 | <1% | 1,351 | $2K | |
| 92579 | <1% | 167 | $2K | |
| 87070 | <1% | 1,811 | $2K | |
| 84484 | <1% | 3,699 | $2K | |
| 84439 | <1% | 593 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 522 | $1K |
| 76801 | <1% | 15 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,748 | $1K |
| 84703 | <1% | 655 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 15,369 | $1K |
| 20552 | <1% | 23 | $956.77 | |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 135 | $935.09 |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $879.17 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 19 | $768.88 |
| 84144 | <1% | 43 | $720.50 | |
| 73030 | <1% | 48 | $714.39 | |
| 73130 | <1% | 14 | $683.50 | |
| 80305 | <1% | 1,053 | $666.86 | |
| 82950 | <1% | 112 | $636.53 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 33 | $633.02 |
| 93320 | <1% | 2,007 | $629.00 | |
| 76536 | <1% | 204 | $610.14 | |
| 73100 | <1% | 14 | $587.64 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,251 | $488.03 |
| A0429 | Emergency ambulance ride, basic life support | <1% | 90 | $411.63 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 470 | $404.28 |
| 87210 | <1% | 730 | $377.20 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 36 | $372.97 |
| 80055 | <1% | 13 | $327.64 | |
| 83735 | <1% | 2,193 | $325.72 | |
| 81003 | <1% | 5,768 | $295.71 | |
| 94762 | <1% | 160 | $294.30 | |
| 94010 | <1% | 469 | $291.67 | |
| 99173 | <1% | 13 | $266.00 | |
| 90677 | <1% | 42 | $262.23 | |
| 93017 | <1% | 41 | $252.82 | |
| 82607 | <1% | 106 | $225.71 | |
| Q3014 | Telehealth originating site facility fee | <1% | 79 | $206.56 |
| 84403 | <1% | 29 | $200.05 | |
| 85007 | <1% | 353 | $181.09 | |
| 85046 | <1% | 52 | $180.60 | |
| 82043 | <1% | 79 | $161.47 | |
| 81025 | <1% | 160 | $152.40 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 946 | $135.40 |
| 97542 | <1% | 12 | $133.16 | |
| 88720 | <1% | 15 | $131.22 | |
| 85018 | <1% | 260 | $96.33 | |
| 90656 | <1% | 13 | $79.56 | |
| 83690 | <1% | 2,995 | $77.92 | |
| 96127 | <1% | 208 | $70.94 | |
| 83605 | <1% | 4,242 | $66.06 | |
| 87400 | <1% | 122 | $62.36 | |
| 86140 | <1% | 8,080 | $47.59 | |
| 81001 | <1% | 5,232 | $42.64 | |
| 94761 | <1% | 3,729 | $36.30 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 501 | $34.04 |
| 87581 | <1% | 499 | $34.04 | |
| 87486 | <1% | 499 | $34.04 | |
| 87186 | <1% | 25 | $33.88 | |
| 86762 | <1% | 116 | $27.61 | |
| 87807 | <1% | 725 | $25.15 | |
| 90647 | <1% | 1,125 | $20.91 | |
| 87340 | <1% | 118 | $19.82 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,951 | $18.66 |
| 82785 | <1% | 12 | $13.17 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,748 | $12.00 |
| 85610 | <1% | 5,265 | $10.38 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,743 | $9.17 |
| 84145 | <1% | 975 | $8.48 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,069 | $8.00 |
| 87077 | <1% | 13 | $7.91 | |
| 83615 | <1% | 61 | $7.08 | |
| G0008 | Administration of influenza virus vaccine | <1% | 62 | $6.54 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,381 | $0.42 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 635 | $0.12 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,614 | $0.10 |
| J2704 | Injection, propofol, 10 mg | <1% | 693 | $0.09 |
| 90785 | 0% | 971 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 1,444 | $0.00 |
| 93325 | 0% | 2,007 | $0.00 | |
| 99152 | 0% | 1,209 | $0.00 | |
| 90633 | 0% | 316 | $0.00 | |
| 90648 | 0% | 242 | $0.00 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 0% | 50 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 53 | $0.00 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 66 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 25 | $0.00 |
| 81002 | 0% | 38 | $0.00 | |
| 90681 | 0% | 37 | $0.00 | |
| 80179 | 0% | 37 | $0.00 | |
| A4649 | Surgical supply; miscellaneous | 0% | 41 | $0.00 |
| 90710 | 0% | 39 | $0.00 | |
| 90715 | 0% | 28 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 138 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 31 | $0.00 |
| 94664 | 0% | 30 | $0.00 | |
| 88312 | 0% | 30 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 13 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 14 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 12 | $0.00 |
| 87280 | 0% | 121 | $0.00 | |
| 90474 | 0% | 4,312 | $0.00 | |
| 95885 | 0% | 284 | $0.00 | |
| 36416 | 0% | 4,125 | $0.00 | |
| 90680 | 0% | 804 | $0.00 | |
| 85730 | 0% | 1,365 | $0.00 | |
| 86901 | 0% | 391 | $0.00 | |
| 86850 | 0% | 362 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 64 | $0.00 |
| 80320 | 0% | 20 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 0% | 790 | $0.00 |
| 95886 | 0% | 666 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 1,659 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 184 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 323 | $0.00 |
| 88342 | 0% | 568 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 151 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 193 | $0.00 |
| 87040 | 0% | 334 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 91 | $0.00 |
| 82150 | 0% | 96 | $0.00 | |
| 86803 | 0% | 48 | $0.00 | |
| 83880 | 0% | 32 | $0.00 | |
| 85379 | 0% | 109 | $0.00 | |
| C1726 | Catheter, balloon dilatation, non-vascular | 0% | 41 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 38 | $0.00 |
| C1769 | Guide wire | 0% | 12 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 34 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 13 | $0.00 |
| 80329 | 0% | 19 | $0.00 | |
| 90696 | 0% | 39 | $0.00 | |
| 82550 | 0% | 15 | $0.00 | |
| 85652 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHUBER, TIMOTHY (CONTROLLER)
| Provider | Location | Paid |
|---|---|---|
| Covenant Medical Center INC | Waterloo, IA | $22.00M |
| Covenant Medical Center INC | Waterloo, IA | $2.06M |
| Mercy Hospital of Franciscan Sisters INC | Oelwein, IA | $1.97M |
| Covenant Medical Center INC | Waterloo, IA | $618K |
| Sartori Memorial Hospital INC | Cedar Falls, IA | $439K |
| Sartori Memorial Hospital INC | Cedar Falls, IA | $313K |
| Covenant Medical Center INC | Arlington, IA | $225K |
| Mercy Hospital of Franciscan Sisters INC | Oelwein, IA | $139K |
| Sartori Memorial Hospital INC | Cedar Falls, IA | $117K |
| Covenant Medical Center INC | Waterloo, IA | $99K |
| Mercy Hospital of Franciscan Sisters INC | Oelwein, IA | $15K |
| Covenant Medical Center INC | Waterloo, IA | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.